Starling Oncology

STLN

----

Current ValuationThe current P/E ratio is -22.38, below the reasonable range, cheaper than 83.05% of the time in the past 1 years, and the industry ranks 21/23, the industry Median 14.85.

-22.38xP/E

Stock price$6.71Earnings per share$-0.30

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.

Industry median 14.85x

05101520

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.

Industry median 14.85x

0x20x40x60x80x100x

P/E ratio
Name/Symbol
ACHCUSAcadia Healthcare	-2.60x	107.17%	$2.93B
BKDUSBrookdale Senior Living	-17.40x	102.72%	$2.41B
SGRYUSSurgery Partners	-23.27x	3.28%	$2.06B
SNDAUSSonida Senior Living	-11.18x	14.93%	$1.62B
STLNUSStarling Oncology	-22.38x	70.00%	$683.86M
RNVAUSRennova Health, Inc.	--	--	$40.55K
IVPRUSInspire Veterinary Partners, Inc.	-0.00x	--	$22.44K

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.